Injectable GLP-1-based therapies, including semaglutide and tirzepatide, have demonstrated substantial benefits for weight loss and cardiometabolic risk reduction ( 1 3 ), but real-world uptake has been shaped by factors such as route of administration, access, tolerability, and insurance coverage ( 4 7 )
Best practices for restarting semaglutide To ensure a smooth restart, consider the following best practices: Begin at the lowest dose: Allow your body to adjust gradually by starting at the lowest available dose
You do not need to worry about oral B12 absorption being compromised by the same medication you are taking
There are other medications, like tirzepatide and liraglutide, that work in similar ways, and some drugs use totally different methods to help people lose weight
Write down every injection date, the number of units drawn, the dose in milligrams, the injection site, and any notes about side effects or observations